Guillain-Barré Syndrome following Treatment with Sunitinib Malate

Sunitinib malate (Sutent, SU011248) is an oral multitargeted tyrosine kinase inhibitor (TKI) used for the treatment of metastatic renal cell carcinoma and imatinib (Gleevec)—resistant gastrointestinal stromal tumor (GIST) with few reported side effects including asthenia, myelosuppression, diarrhea,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kanaan, Ziad, Kulairi, Zain, Titianu, Mirela, Saha, Sandip, Kumar, Sarwan
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2014
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4074976/
https://ncbi.nlm.nih.gov/pubmed/25018885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/712040
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars